2BBBullish & Bearish
Verastem, Inc. (VSTM) trades on NASDAQ. It operates in the Health Care sector, Biotechnology industry. Its current 2BB score is 65 out of 100.
Verastem, Inc., doing business as Verastem Oncology, is an American pharmaceutical company that develops medicines to treat certain cancers. Headquartered and founded in Boston, Massachusetts, the firm is a member of NASDAQ Biotechnology Index.
Verastem, Inc.’s current 2BB score is 65 out of 100, built from the signal categories below.
| Signal | Score | Reading |
|---|---|---|
| Activity | 75 | High |
| Momentum | 62 | Improving |
| Financial strength | 30 | Weak |
| Quality | 100 | Very Strong |
| Risk | 50 | Moderate |
| CEO | Brian Stuglik |
| Headquarters | Needham, Massachusetts, United States |
| Founded | 2010 |
| Employees | 102 |
| 52-week range | $3.43 – $11.24 |
| Report date | EPS actual | EPS estimate | Revenue actual | Revenue estimate |
|---|---|---|---|---|
| 2026-11-02 | — | -0.4538 | — | $29.71M |
| 2026-08-06 | — | -0.4413 | — | $23.56M |
| 2026-05-07 | -0.46 | -0.4703 | $18.67M | $22.01M |
| 2026-02-04 | — | -0.5383 | — | $16.60M |